tm logo
QADYNA
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 09 Sep 2022

Last Applicant/ Owned by

100 Acorn Park Drive, 5th Floor

Cambridge

MA

02140

Serial Number

85143129 filed on 01st Oct 2010

Registration Number

4106454 registered on 28th Feb 2012

in the Principal Register

Correspondent Address

Richard A. Friedman

Pfizer Inc.

235 East 42nd Street

New York NY 10017

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

QADYNA

Orally administered pharmaceutical preparations available by prescription only, for the treatment of a rare protein misfolding disease, namely, amyloidosis

Classification Information


Class [005]
Pharmaceutical Products


Orally administered pharmaceutical preparations available by prescription only, for the treatment of a rare protein misfolding disease, namely, amyloidosis


First Use Date in General

30th Nov 2011

First Use Date in Commerce

30th Nov 2011

Mark Details


Serial Number

No 85143129

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T 385155

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Sep 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
28th Feb 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11th Mar 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11th Mar 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
11th Mar 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20th Feb 2018TEAS SECTION 8 RECEIVED
28th Feb 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28th Feb 2012REGISTERED-PRINCIPAL REGISTER
26th Jan 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
25th Jan 2012LAW OFFICE REGISTRATION REVIEW COMPLETED